Adrian Adams
2016 - Aralez Pharmaceuticals
In 2016, Adrian Adams earned a total compensation of $8M as Chief Executive Officer at Aralez Pharmaceuticals, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $700,000 |
|---|---|
| Option Awards | $174,666 |
| Salary | $700,000 |
| Stock Awards | $1,373,981 |
| Other | $5,085,997 |
| Total | $8,034,644 |
Adams received $5.1M in other compensation, accounting for 63% of the total pay in 2016.
Adams also received $700K in non-equity incentive plan, $174.7K in option awards, $700K in salary and $1.4M in stock awards.
Rankings
In 2016, Adrian Adams' compensation ranked 758th out of 14,075 executives tracked by ExecPay. In other words, Adams earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 758 out of 14,075 | 95th |
Division Manufacturing | 243 out of 5,489 | 96th |
Major group Chemicals And Allied Products | 63 out of 1,895 | 97th |
Industry group Drugs | 41 out of 1,538 | 97th |
Industry Pharmaceutical Preparations | 33 out of 1,176 | 97th |
Source: SEC filing on March 23, 2017.
Adams' colleagues
We found four more compensation records of executives who worked with Adrian Adams at Aralez Pharmaceuticals in 2016.